Bharat Biotech promoter Krishna Ella is new President of IVMA

Hyderabad: The Indian Vaccine Manufacturers Association has announced Krishna M Ella, Co-Founder, Executive Chairman of Bharat Biotech as the association's new President for a two-year period from April 2024. "Vaccines are the vital pillar of global health, and the IVMA mission is to ensure that every individual, regardless of where they live, has access to life-saving immunizations," Ella said adding "innovation, sustainability, and equity are the foundations of our collective vision, and I am pleased to serve IVMA along with its distinguished members and contribute to its vision to protect and enhance public health in India and the developing world." He emphasized the need to support African nations' public health vision by IVMA members and also urged to formulate policies and regulations in line with WHO and US FDA, which will help the industry to be not only globally competitive but also fortify India's vision to boost the level playing field world-over in preventive care. IVMA's mission is to bring to the fore the Indian private sector human vaccine manufacturer's concerns related to the progress and profitability of the industry and in streamlining regulatory pathways and matters related to audits and inspections in consultations with the national Central Drugs Standard and Control Organization.